glycolic acid
Small moleculeexperimental
Glycolic acid is a colorless, odorless and hygroscopic crystalline solid, highly soluble in water. It is used in various skin-care products. Glycolic acid is widespread in nature. A glycolate is a salt or ester of glycolic acid. — Wikipedia
Clinical trial activity
12 trials · 14 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
5
Phase 3
1
Phase 4
4
Earliest trial started Feb 1, 2006 (NCT01589523)
Timeline
Indications
Approved for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Loading structure…
SMILES
O=C(O)CO- Mol. weight
- 76.05 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- Yes
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaGlycolic acid ↗
- ChEMBLCHEMBL252557 ↗
- ChEMBLCHEMBL2107965 ↗
Also known as
- 2-hydroxyacetic acid
- 2-hydroxyacetic acid
- 2-hydroxyethanoic acid
- 2-hydroxyethanoic acid
- alpha-hydroxyacetic acid
- alpha-hydroxyacetic acid
- glycolate
- glycolic acid
- glycolic acid
- glycolic acid
- glycolic acid
- glycolic acid
- glycolic acid
- glycolic acid
- glycolic acid, 1-(14)c-labeled
- glycolic acid, 2-(14)c-labeled
- glycolic acid, calcium salt
- glycolic acid, monoammonium salt
- glycolic acid, monolithium salt
- glycolic acid, monopotassium salt
- glycolic acid, monosodium salt
- glycolic acid, potassium salt
- glycollic acid
- glycollic acid
- hydroxyacetic acid
- hydroxyacetic acid
- hydroxyacetic acid
- hydroxyacetic acid
- hydroxyethanoic acid
- hydroxyethanoic acid
- hydroxyethanoic acid
- potassium glycolate
- α-hydroxyacetic acid
- α-hydroxyacetic acid
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05471947 | Phase 4 | Sep 1, 2022 | Main Line Center for Laser Surgery |
| NCT05362500 | Phase 1 | Jun 1, 2021 | Government of Pakistan |
| NCT03153852 | Phase 4 | Dec 15, 2017 | Assiut University |
| NCT02812719 | Early Phase 1 (Phase 1) | Dec 1, 2017 | Boston University |
| NCT03192306 | Phase 2 | Jul 5, 2017 | Accelovance, Benu BioPharma, Inc., Optimal Research, Topical Remedy |
| NCT02126657 | Phase 2 | May 1, 2014 | National University of Singapore |
| NCT02126644 | Phase 2 | May 1, 2014 | National University of Singapore |
| NCT02052752 | Phase 4 | Feb 1, 2014 | GlaxoSmithKline |
| NCT01985321 | Phase 2 | Nov 1, 2013 | Benu BioPharma, Inc., Topical Remedy |
| NCT01289171 | N/A | Jan 1, 2009 | NeoStrata Company, Inc., University of Pennsylvania |
| NCT00472966 | Phase 4 | Nov 1, 2006 | Galderma |
| NCT01589523 | Phase 3 | Feb 1, 2006 | University of Cincinnati |
Showing 12 of 12 trials
Page 1 / 1
Organizations
Research & Development (14)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Benu BioPharma, Inc. | For profit | 2 | 0 | 1 | 2013 |
| National University of Singapore | Academic/Hospital | 2 | 2 | 1 | 2014 |
| Topical Remedy | For profit | 2 | 2 | 1 | 2013 |
| Accelovance | For profit | 1 | 0 | 1 | 2017 |
| Assiut University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Boston University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Galderma | For profit | 1 | 1 | 1 | 2006 |
| GlaxoSmithKline | For profit | 1 | 1 | 1 | 2014 |
| Government of Pakistan | Government | 1 | 1 | 1 | 2021 |
| Main Line Center for Laser Surgery | Academic/Hospital | 1 | 1 | 1 | 2022 |
| NeoStrata Company, Inc. | For profit | 1 | 0 | 1 | 2009 |
| Optimal Research | For profit | 1 | 0 | 1 | 2017 |
| University of Cincinnati | Academic/Hospital | 1 | 1 | 1 | 2006 |
| University of Pennsylvania | Academic/Hospital | 1 | 1 | 1 | 2009 |
14 organizations
Page 1 / 1